Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

scPharmaceuticals Inc. - Common Stock (NQ:SCPH)

5.570 -0.010 (-0.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 586,082
Open 5.590
Bid (Size) 5.550 (50)
Ask (Size) 5.850 (1)
Prev. Close 5.580
Today's Range 5.550 - 5.620
52wk Range 1.940 - 6.280
Shares Outstanding 35,769,073
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Unusual volume stocks in Friday's session
Let's explore the current happenings on the US markets on Friday. Below, you'll find the stocks exhibiting unusual volume in today's session. 
Via Chartmill
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMXI, HBI, VTLE, SCPH on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire

Performance

YTD
+56.0%
+56.0%
1 Month
+5.9%
+5.9%
3 Month
+32.6%
+32.6%
6 Month
+90.1%
+90.1%
1 Year
+7.3%
+7.3%

More News

Read More
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: scPharmaceuticals Inc. (Nasdaq – SCPH), Vital Energy, Inc. (NYSE – VTLE), International Money Express, Inc. (Nasdaq - IMXI), HanesBrands Financial Corp. (NYSE - HBI)
From Brodsky & Smith LLC
Via GlobeNewswire
Earnings Scheduled For August 7, 2025
Via Benzinga
Insights Ahead: scPharmaceuticals's Quarterly Earnings
Via Benzinga
SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH
From Kahn Swick & Foti, LLC
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VTLE and SCPH on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
MannKind’s $360M scPharma Deal Splits Analysts — Retail Traders Call It ‘Bizarro Territory’ But Stay Bullish
Via Stocktwits
Earnings Scheduled For November 13, 2024
Via Benzinga
scPharmaceuticals's Earnings Outlook
Via Benzinga
MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal
Via Benzinga
SCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of scPharmaceuticals Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Which stocks are moving before the opening bell on Monday?
Via Chartmill
Shareholder Alert: The Ademi Firm Investigates Whether scPharmaceuticals Inc. Is Obtaining a Fair Price for Its Public Shareholders
From Ademi & Fruchter LLP
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
MannKind Corporation to Acquire scPharmaceuticals: More Details Inside
Via Stocktwits
MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases
From MannKind
Via GlobeNewswire
SCPH Revenue Up 99%
Via The Motley Fool
Which stocks are moving before the opening bell on Tuesday?
Via Chartmill
Analyst Expectations For scPharmaceuticals's Future
Via Benzinga
scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
From scPharmaceuticals Inc.
Via GlobeNewswire
Earnings Scheduled For May 14, 2025
Via Benzinga
Earnings Scheduled For March 19, 2025
Via Benzinga
Wondering what's happening in today's after-hours session?
Via Chartmill
scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease
From scPharmaceuticals Inc.
Via GlobeNewswire

Frequently Asked Questions

Is scPharmaceuticals Inc. - Common Stock publicly traded?
Yes, scPharmaceuticals Inc. - Common Stock is publicly traded.
What exchange does scPharmaceuticals Inc. - Common Stock trade on?
scPharmaceuticals Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for scPharmaceuticals Inc. - Common Stock?
The ticker symbol for scPharmaceuticals Inc. - Common Stock is SCPH on the Nasdaq Stock Market
What is the current price of scPharmaceuticals Inc. - Common Stock?
The current price of scPharmaceuticals Inc. - Common Stock is 5.570
When was scPharmaceuticals Inc. - Common Stock last traded?
The last trade of scPharmaceuticals Inc. - Common Stock was at 09/05/25 04:00 PM ET
What is the market capitalization of scPharmaceuticals Inc. - Common Stock?
The market capitalization of scPharmaceuticals Inc. - Common Stock is 199.23M
How many shares of scPharmaceuticals Inc. - Common Stock are outstanding?
scPharmaceuticals Inc. - Common Stock has 199M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.